Market revenue in 2023 | USD 468.5 million |
Market revenue in 2030 | USD 1,211.9 million |
Growth rate | 14.5% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.34% in 2023. Horizon Databook has segmented the Asia Pacific clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to be one of the fastest growing regions in clinical trial biorepository & archiving solutions market. The tremendous growth in clinical research is expected to drive growth of clinical trial biorepository & archiving solutions market in the region.
Primary factors driving the growth of clinical research in these regions include low cost per patient in Asia Pacific countries and presence of a diverse group of patients that are easy to recruit.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account